# Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST‐CLI) Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/design-and-rationale-of-the-best-endovascular-versus-best-surgical-therapy-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Matthew T. Menard,Alik Farber,Susan F. Assmann,Niteesh K. Choudhry,Michael S. Conte,Mark A. Creager,Michael D. Dake,Michael R. Jaff,John A. Kaufman,Richard J. Powell,Diane Reid,Flora S. Siami,George Sopko,Christopher J. White,Kenneth Rosenfield |
| Citations | 232 |
| DOI | 10.1161/jaha.116.003219 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1161/jaha.116.003219 |
| OpenAlex ID | https://openalex.org/W2465379097 |
| PMID | 27402237 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Matthew T. Menard](https://scholariq.org/researchers/matthew-t-menard/)
- [Michael S. Conte](https://scholariq.org/researchers/michael-s-conte/)
- [Alik Farber](https://scholariq.org/researchers/alik-farber/)
- [Michael D. Dake](https://scholariq.org/researchers/michael-d-dake/)
- [Mark A. Creager](https://scholariq.org/researchers/mark-a-creager/)

## Paper journal

- [Journal of the American Heart Association](https://scholariq.org/journals/journal-of-the-american-heart-association/)

## Paper primary topic

- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)

## Paper topics

- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)
- [Lymphatic System and Diseases](https://scholariq.org/topics/lymphatic-system-and-diseases/)
- [Cerebrovascular and Carotid Artery Diseases](https://scholariq.org/topics/cerebrovascular-and-carotid-artery-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.